{
    "id": "correct_subsidiary_00122_1",
    "rank": 32,
    "data": {
        "url": "https://discovery-patsnap-com.libproxy.mit.edu/topic/coronary-artery-bypass-surgery/",
        "read_more_link": "",
        "language": "en",
        "title": "Top 20 Coronary artery bypass surgery companies - Discovery",
        "top_image": "https://discovery-patsnap-com.libproxy.mit.edu/company/favicon.png",
        "meta_img": "https://discovery-patsnap-com.libproxy.mit.edu/company/favicon.png",
        "images": [
            "https://discovery-static-patsnap-com.libproxy.mit.edu/seo/client/company/svg/logo.svg",
            "https://discovery-static-patsnap-com.libproxy.mit.edu/seo/client/img/icon-light.2495fb1.jpg",
            "https://discovery-static-patsnap-com.libproxy.mit.edu/seo/client/img/icon-light.2495fb1.jpg",
            "https://discovery-static-patsnap-com.libproxy.mit.edu/seo/client/img/company-competitive.6933519.jpg",
            "https://discovery-static-patsnap-com.libproxy.mit.edu/seo/logo/organization/entity/master_entity_128/79cd/344d/a5c6/3b60/691a/14c6/89c2/8ddd/ba7dcc920926dad5.jpeg",
            "https://discovery-static-patsnap-com.libproxy.mit.edu/seo/client/company/svg/company-placeholder.svg",
            "https://discovery-static-patsnap-com.libproxy.mit.edu/seo/logo/organization/entity/master_entity_128/9bde/324e/eb85/b274/1a1c/90c0/d405/d320/ecfe4d6d0731fb89.png",
            "https://discovery-static-patsnap-com.libproxy.mit.edu/seo/client/company/svg/company-placeholder.svg",
            "https://discovery-static-patsnap-com.libproxy.mit.edu/seo/logo/organization/entity/master_entity_128/1af8/6444/fb46/5afb/7a42/d895/4d63/815a/941bb47daa8a995e.jpeg",
            "https://discovery-static-patsnap-com.libproxy.mit.edu/seo/client/company/svg/company-placeholder.svg",
            "https://discovery-static-patsnap-com.libproxy.mit.edu/seo/logo/organization/entity/master_entity_128/f3bc/5e16/bff0/6f0b/afcf/6937/a43b/35e4/0a0515f4f53ad820.jpeg",
            "https://discovery-static-patsnap-com.libproxy.mit.edu/seo/logo/organization/entity/master_entity_128/89f7/1fbb/4b83/ef73/11fc/8028/c310/6c6c/a8b5bf5b8b6c7f29.png",
            "https://discovery-static-patsnap-com.libproxy.mit.edu/seo/logo/organization/entity/master_entity_128/bf49/d867/8345/d740/c195/5246/51c2/9d21/50fdd2bc7ba6b57e.png",
            "https://discovery-static-patsnap-com.libproxy.mit.edu/seo/logo/organization/entity/master_entity_128/4985/813e/755f/df29/a1f8/c063/739c/1ada/f2cd859f47a87a4f.png",
            "https://discovery-static-patsnap-com.libproxy.mit.edu/seo/client/company/svg/company-placeholder.svg",
            "https://discovery-static-patsnap-com.libproxy.mit.edu/seo/logo/organization/entity/master_entity_128/c31f/07f3/19b8/09ab/37f5/dfb6/3c92/5625/c58b2eb0234e5565.png",
            "https://discovery-static-patsnap-com.libproxy.mit.edu/seo/logo/organization/entity/master_entity_128/c1ff/2777/c36c/605b/dc6f/b986/fe3f/4647/a406e1c19fc8945e.png",
            "https://discovery-static-patsnap-com.libproxy.mit.edu/seo/logo/organization/entity/master_entity_128/17b5/8950/0005/5235/03f1/8af5/3f20/8702/112ecf8d4c73b305.jpeg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            "Coronary artery bypass surgery",
            "technical research",
            "competitor monitor",
            "market trends",
            "company profile",
            "discovery",
            "PatSnap"
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "Coronary artery bypass surgery, also known as coronary artery bypass graft (CABG, pronounced \"cabbage\") surgery, and colloquially heart bypass or bypass surgery, is a surgical procedure to restore normal blood flow to an obstructed coronary artery. A normal coronary artery transports blood to and from the heart muscle itself, not through the main circulatory system.",
        "meta_lang": "en",
        "meta_favicon": "/company/favicon.png",
        "meta_site_name": "",
        "canonical_link": "https://discovery-patsnap-com.libproxy.mit.edu/topic/coronary-artery-bypass-surgery/",
        "text": "Heartport is an entrepreneurial medical device maker that has introduced several innovative systems for conducting less-invasive cardiac surgery. The company was founded by John H. Stevens and Wesley D. Sterman. Heartport manufactures and markets less invasive cardiac surgery products that enable surgeons to perform a wide range of less invasive open-chest and minimally invasive heart operations, including stopped heart and beating heart procedures. In April 2001, Heartport was merged with and into CARDIOVATIONS, a wholly-owned subsidiary of Johnson & Johnson. Heartport continues to operate as a part of the division of Ethicon, Inc., a Johnson & Johnson company. Ethicon is a global leader in developing and marketing products for surgery in the areas of wound closure and wound management, surgical sports medicine, women's health and cardiovascular surgery.\n\nMAQUET Cardiovascular LLC, a subsidiary of Getinge AB, is an American company located in Wayne, NJ. The firm develops and distributes therapeutic medical equipment.\\nThe company says this about itself: Maquet is part of Getinge Group, a leading global provider of innovative solutions for operating rooms, intensive-care units, hospital wards, sterilization departments, elderly care and for life science companies and institutions. Getinge Group operates under the three brands of ArjoHuntleigh, Getinge and Maquet. With a genuine passion for life we build quality and safety into every system. Our unique value proposition mirrors the continuum of care, enhancing efficiency throughout the clinical pathway. Based on our first-hand experience and close partnerships, we are able to exceed expectations from customers �� improving the every-day life for people, today and tomorrow.\n\nSumitomo Bakelite Company manufactures and sells semiconductor materials, and circuit and plastic products in Asia, North America, and Europe. It offers epoxy resin molding compounds and liquid epoxy resins for encapsulation of semiconductor devices, adhesive tapes for assembling semiconductors, coating resins for semiconductor wafers, and pastes for die bonding; and phenolic resins, thermoset plastic molding compounds, epoxy coating powders, heat dissipative materials, and molded parts and molding dies, as well as resins for photoresist, and circuitry materials. The company also provides co-extruded multilayered films and sheets for industrial use and food packaging, heat-resistant PVC sheets, engineering plastics films, pharmaceutical products packaging materials, packaging materials for cosmetics and toiletry products, dicing tapes, PVC and PETG sheets for plastic cards, and carrier tape materials; polycarbonate plates, anti-static plates, ABS plates, acrylic and polystyrene decorative plates, PET plates, PVC plates, PC/ABS alloy plates, and modified polystyrene sheets, as well as halogen-free, flame retardant, and heat resistant sheets; and high-pressure laminates (HPL), high design HPL, flame retardant HPL, melamine-faced solid panels, melamine-faced doors, postform counters, polyester plywoods, edge tapes, high-performance HPL, and laminates. In addition, it offers flexible printed circuits; endoscopic devices, surgery/drainage, and circulation/IVR; substrate materials for semiconductor packages; glycan related products, cryogenic vials, cell culture products, nerve-cell culture system, centrifuge tubes/conical tubes, and low protein adsorption products and ELISA; packaging for producers and vegetable factories, and freshness-keeping zipper bags for household use; and waterproofing for rooftop and pitched roof, solar-cell-integrated waterproof sheets, and waterproofing systems. The company was founded in 1907 and is headquartered in Tokyo, Japan.\n\nBeth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts is a teaching hospital of Harvard Medical School. It was formed out of the 1996 merger of Beth Israel Hospital (founded in 1916) and New England Deaconess Hospital (founded in 1896). Among independent teaching hospitals, Beth Israel Deaconess Medical Center consistently ranks in the top three recipients of biomedical research funding from the National Institutes of Health. Research funding totals nearly $200 million annually. BIDMC researchers run more than 850 active sponsored projects and 200 clinical trials. The Harvard-Thorndike General Clinical Research Center, the oldest clinical research laboratory in the United States, has been located on this site since 1973.\n\nCardioThoracic Systems, Inc., located in Cupertino, Calif., is a leading\\ndeveloper of proprietary technologies in minimally invasive cardiothoracic\\nsurgery. CTS introduced its first generation system for minimally invasive\\nbeating heart bypass surgery in January 1997. Since that time, over 11,000\\nbeating heart bypass procedures, including midline and thorocotomy approaches, have been performed using CTS' propriety instruments. CTS is also developing technologies in the area of minimally invasive valve repair. CardioThoracic Systems, Inc., has been acquired by Guidant in 1999.\n\nDyax Corp. (Dyax) is a biopharmaceutical company focused on the discovery, development and commercialization of biotherapeutics for unmet medical needs, with an emphasis on inflammatory and oncology indications. The Company's lead product, DX-88, has been approved under the brand name KALBITOR (ecallantide) by the United States Food and Drug Administration (FDA) for treatment of acute attacks of hereditary angioedema (HAE) in patients 16 years of age and older. The Company commercializes KALBITOR on its own in the United States. In addition to its approved commercial use for HAE in the United States, the Company is also developing DX-88 through collaborations in other indications. These include use of DX-88 for the reduction of blood loss during surgery in collaboration with Cubist Pharmaceuticals (Cubist), and for treatment of retinal diseases in collaboration with Fovea Pharmaceuticals (Fovea), which was acquired by sanofi-aventis during the year ended December 31, 2009.\n\nAesculap AG engages in the development, manufacture, and distribution of precision, medical, as well as medical technology instruments. It also offers medical apparatus, prostheses, implants, suture materials, laboratory and hospital supplies, as well as equipment for the manufacture of medical and medical technology devices. The company was founded in 1867 and is headquartered in Tuttlingen, Germany."
    }
}